Fen1 mutations result in autoimmunity, chronic inflammation and cancers

Li Zheng(Hebei Agricultural University), Binghui Shen(Changchun University of Science and Technology), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Purnima Singh(City Of Hope National Medical Center), Mian Zhou(Nanjing Drum Tower Hospital), Mei Li(Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine), Xuemei Zhang(Weifang Medical University), Dongxin Lin(Sun Yat-sen University), Huifang Dai(City Of Hope National Medical Center), Kemp H. Kernstine(The University of Texas Southwestern Medical Center), Junzhuan Qiu(City Of Hope National Medical Center), Walter Tsark
Nature Medicine
June 24, 2007
10.1038/nm1599
Cited by 249

Related Papers

Lactate Metabolism in Human Lung Tumors
|Cell|2017|1.3k
Metabolic Heterogeneity in Human Lung Tumors
|Cell|2016|1.1k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
|Molecular Therapy|2013|624
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558